PRPS1 and viral infectious disease: The immunity and growth phenotypes of pals-17 mutants are dependent on the positive IPR regulators pals-16 and pals-20. Consistent with pals-20 being an activator of the IPR, we find that overexpression of pals-20 in a wild-type background promotes resistance to viral infection.